Susceptibility testing: Phenotypic and genotypic tests for bacteria and mycobacteria

Infectious Disease Clinics of North America

Volumn 15, Issue 4, 2001, Pages 1205-1226

  Louie, Marie ^a,b   Cockerill, Franklin R ^c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^c MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEPHALOSPORIN DERIVATIVE; ETHAMBUTOL; ISONIAZID; MACROLIDE; PENICILLIN DERIVATIVE; PSEUDOMONIC ACID; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN; VANCOMYCIN;

AGAR GEL DIFFUSION; ANAEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ASSAY; DILUTION; FLOW CYTOMETRY; GENOTYPE; LABORATORY TEST; MOLECULAR BIOLOGY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; REVIEW;

EID: 0035217997     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70191-4     Document Type: Article

References (114)

1. Applications of flow cytometry to clinical microbiology
2. Interim guidelines for prevention and control of staphylococcal infection associated with reduced susceptibility to vancomycin
3. Recommendations for preventing the spread of vancomycin resistance: Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC)
4. Reduced susceptibility of Staphylococcus aureus to vancomycin - Japan, 1996
5. Update: Staphylococcus aureus with reduced susceptibility to vancomycin - United States, 1997
6. Use of the polymerase chain reaction for rapid detection of high-level mupirocin resistance in staphylococci
7. Molecular characterization by PCR-restriction fragment length polymorphism of TEM beta-lactamases
8. Comparison of the E Test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria
9. Rapid assay for detection of methicillin-resistant Staphylococcus aureus using multiplex PCR
10. Redefining MDR-TB transmission 'hot spots
11. Rapid detection of the meca gene in methicillin resistant staphylococci using a colorimetric cycling probe technology
12. Preventing antibiotic resistance through rapid genotypic identification of bacteria and of their antibiotic resistance genes in the clinical microbiology laboratory
13. Detection of the mec-A gene and phenotypic detection of resistance in Staphylococcus aureus isolates with borderline or low-level methicillin resistance
14. Should we vigorously try to contain and control methicillin-resistant Staphylococcus aureus?
15. Detection of Staphylococcus aureus by polymerase chain reaction amplification of the nuc gene
16. Reliability of the MB/BacT system for testing susceptibility of Mycobacterium tuberculosis complex isolates to antituberculous drugs
17. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: An update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System
18. Drug-resistant Streptococcus pneumoniae
19. Evaluation of MRSA-Screen, a simple anti-PBP 2a slide latex agglutination kit, for rapid detection of methicillin resistance in Staphylococcus aureus
20. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada
21. Evaluation of the E test for susceptibility testing of anaerobic bacteria
22. Conventional and genetic laboratory tests used to guide antimicrobial therapy
23. Genetic methods for assessing antimicrobial resistance
24. Rapid identification of a point mutation of the Mycobacterium tuberculosis catalase-peroxidase (katG) gene associated with isoniazid resistance
25. Methicillin-resistant Staphylococcus aureus in the community: New battlefronts, or are the battles lost?
26. Evaluation of laboratory tests for detection of methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis
27. Qualitative susceptibility tests versus quantitative MIC tests
28. Evaluation of the MB/BacT mycobacterium detection system for susceptibility testing of Mycobacterium tuberculosis
29. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States
30. Application of pbp1A PCR in identification of penicillin-resistant Streptococcus pneumoniae
31. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR
32. The emergence of streptococcus pneumoniae resistant to macrolide antimicrobial agents: A 6-year population-based assessment
33. Multiplex PCR for identification of methicillin-resistant staphylococci in the clinical laboratory
34. Discovery and development of new antimicrobial agents
35. Towards a common susceptibility testing method?
36. Detection of antibiotic resistance in vitro
37. Screening and confirmatory testing for extended spectrum beta-lactamases (ESBL) in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca clinical isolates
38. Spiral gradient endpoint: A new method of susceptibility testing
39. Antimicrobial susceptibility testing of gram-negative bacteria: Meeting the challenge of increasing resistance and decreasing budgets
40. Susceptibility testing of fastidious bacteria
41. Glycopeptide-intermediate Staphylococcus aureus: Evaluation of a novel screening method and results of a survey of selected U.S. hospitals
42. Antimycobacterial agents and susceptibility tests
43. Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli
44. Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae
45. Evaluation of e test for susceptibility testing of mycobacterium tuberculosis
46. Antimicrobial susceptibility testing: Special needs for fastidious organisms and difficult-to-detect resistance mechanisms
47. Antimicrobial susceptibility testing: General principles and contemporary practices
48. Antibacterial susceptibility tests: Dilution and disk diffusion methods
49. Mycobacterium tuberculosis susceptibility results in 24 hours by using flow cytometry
50. Rapid diagnosis of methicillin-resistant Staphylococcus aureus bacteremia by nested polymerase chain reaction
51. Comparison of agar dilution, broth microdilution, E-test, disk diffusion, and automated Vitek methods for testing susceptibilities of Enterococcus spp. to vancomycin
52. Branched-DNA assay for detection of the meca gene in oxacillin-resistant and oxacillin-sensitive staphylococci
53. Responsibility of the infectious disease community for optimal use of antibiotics: Views of the membership of the Infectious Diseases Society of America
54. Trends in antimicrobial resistance among clinical isolates of the Bacteroides fragilis group from 1992 to 1997 in Montreal, Canada
55. Resistance to glycopeptides in enterococci
56. Using oligonucleotide probe arrays to access genetic diversity
57. Genotypic determination of mycobacterium tuberculosis antibiotic resistance using a novel mutation detection method, the branch migration inhibition M. tuberculosis antibiotic resistance test
58. Rapid detection of methicillin-resistant staphylococci directly from blood cultures using multiplex PCR
59. Evaluation of three rapid methods for detection of methicillin resistance in Staphylococcus aureus
60. Identification of methicillin-resistant strains of staphylococci by polymerase chain reaction
61. Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: Restricted array of mutations associated with drug resistance
62. Detection of resistance to isoniazid, rifampin, and streptomycin in clinical isolates of Mycobacterium tuberculosis by molecular methods
63. A rapid latex agglutination assay for the detection of penicillin-binding protein 2′
64. Comparison of several methods to determine methicillin-resistance in Staphylococcus aureus with focus on borderline strains
65. Distribution of mefE and ermB genes in macrolide-resistant strains of Streptococcus pneumoniae and their variable susceptibility to various antibiotics
66. Detection of genes coding for extended-spectrum SHV β-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test
67. Detection of ileS-2 gene encoding mupirocin resistance in methicillin-resistant Staphylococcus aureus by multiplex PCR
68. Methods for susceptibility testing of anaerobic bacteria
69. Evaluation of mycobacteria growth indicator tube for recovery and drug susceptibility testing of Mycobacterium tuberculosis isolates from respiratory specimens
70. Principles of molecular testing methods
71. Multiplex PCR detection of vanA, vanB, vanC-1, and vanC-2/3 genes in enterococci
72. In vitro nucleic acid amplification techniques
73. Genotypic detection of antimicrobial resistance
74. Susceptibility testing: Fungi
75. Discrimination of methicillin-resistant Staphylococcus aureus from borderline-resistant and susceptible isolates by different methods
76. Laboratory tests used to guide antimicrobial therapy
77. Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis
78. Comparison of susceptibility testing of Mycobacterium tuberculosis using the ESP culture system II with that using the BACTEC method
79. Multicenter evaluation of the mycobacteria growth indicator tube for testing susceptibility of Mycobacterium tuberculosis to firstline drugs
80. Detection and surveillance of antimicrobial resistance
81. Surveillance for the emergence and dissemination of antimicrobial resistance in bacteria
82. Detection of vancomycin-resistant enterococci in fecal samples by PCR
83. Susceptibility testing: Viral pathogens
84. Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996
85. Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994
86. Characterization of rpsL and rrs mutations in streptomycin-resistant Mycobacterium tuberculosis isolates from diverse geographic localities
87. Analysis of the oxyR-ahpC region in isoniazidresistant and -susceptible Mycobacterium tuberculosis complex organisms recovered from diseased humans and animals in diverse localities
88. Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms
89. Ethambutol resistance in Mycobacterium tuberculosis: Critical role of embB mutations
90. Special phenotypic methods for detecting antibacterial resistance
91. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations
92. Molecular diagnostics of infectious diseases
93. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: A blind study at reference laboratory level
94. Use of polymerase chain reaction single-strand conformation polymorphism (PCR-SSCP) analysis to detect a point mutation in the catalase-peroxidase gene (katG) of Mycobacterium tuberculosis
95. Antimicrobial susceptibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis
96. Bauer and Kirby meet Watson and Crick: Antimicrobial susceptibility testing in the molecular era
97. The resurgence of tuberculosis: Is your laboratory ready?
98. Development of PCR assays to detect ampicillin resistance genes in cerebrospinal fluid samples containing Haemophilus influenzae
99. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides
100. Rapid detection of the meca gene in methicillin-resistant staphylococci by enzymatic detection of polymerase chain reaction products
101. Specific detection of methicillin-resistant Staphylococcus species by multiplex PCR
102. Relevance of antibiotic susceptibility testing for clinical practice
103. Methicillin-resistant Staphylococcus aureus in Europe
104. Decrease in antibiotic susceptibility or increase in resistance?
105. Evaluation of stability of cefotaxime (30-microg) and ceftazidime (30-microg) disks impregnated with clavulanic acid (10 microg) for detection of extended-spectrum beta-lactamases
106. Susceptibility testing of anaerobic bacteria-the state of the art
107. Comparison of spiral gradient endpoint and agar dilution methods for susceptibility testing of anaerobic bacteria: A multilaboratory collaborative evaluation
108. Susceptibility testing for mycobacteria
109. Reporting susceptibility test results-are we really communicating with physicians?